Omkar Pharmachem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2026 ,inter alia, to consider and approve Unaudited Standalone Financial ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Omkar Pharmachem Ltd has informed BSE that its Board of Directors will meet on Saturday, 14 February 2026 at 4:30 P.M. at the registered office in Ahmedabad. The main agenda is to consider and approve the Unaudited Standalone Financial Results for the quarter and nine months ended 31 December 2025. The company has also clarified that the trading window for dealing in its shares will remain closed for designated persons and their immediate relatives until 16 February 2026. This is a routine regulatory intimation under SEBI LODR Regulation 29(1)(a), and no actual financial numbers have been disclosed in this filing.
No direct impact on stock price from this filing as it only announces the upcoming board meeting date. Investors should watch for the actual Q3 FY26 results announcement on or after 14 February 2026, which will provide clarity on revenue, profit, and margins. The closed trading window until 16 February means insiders cannot trade during this period.